Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2013 3
2014 3
2016 4
2017 3
2018 1
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Toward steroidal anticancer drugs: Non-parametric and 3D-QSAR modeling of 17-picolyl and 17-picolinylidene androstanes with antiproliferative activity on breast adenocarcinoma cells.
Kovačević SZ, Karadžić MŽ, Vukić DV, Vukić VR, Podunavac-Kuzmanović SO, Jevrić LR, Ajduković JJ. Kovačević SZ, et al. Among authors: podunavac kuzmanovic so. J Mol Graph Model. 2019 Mar;87:240-249. doi: 10.1016/j.jmgm.2018.12.010. Epub 2018 Dec 17. J Mol Graph Model. 2019. PMID: 30594032
Lipophilicity estimation and characterization of selected steroid derivatives of biomedical importance applying RP HPLC.
Jevrić LR, Karadžić MŽ, Mandić AI, Podunavac Kuzmanović SO, Kovačević SZ, Nikolić AR, Oklješa AM, Sakač MN, Penov Gaši KM, Stojanović SZ. Jevrić LR, et al. Among authors: podunavac kuzmanovic so. J Pharm Biomed Anal. 2017 Feb 5;134:27-35. doi: 10.1016/j.jpba.2016.11.015. Epub 2016 Nov 10. J Pharm Biomed Anal. 2017. PMID: 27871054
Preselection of A- and B- modified d-homo lactone and d-seco androstane derivatives as potent compounds with antiproliferative activity against breast and prostate cancer cells - QSAR approach and molecular docking analysis.
Kovačević SZ, Podunavac-Kuzmanović SO, Jevrić LR, Vukić VR, Savić MP, Djurendić EA. Kovačević SZ, et al. Among authors: podunavac kuzmanovic so. Eur J Pharm Sci. 2016 Oct 10;93:107-13. doi: 10.1016/j.ejps.2016.08.009. Epub 2016 Aug 5. Eur J Pharm Sci. 2016. PMID: 27503457
On the characterization of novel biologically active steroids: Selection of lipophilicity models of newly synthesized steroidal derivatives by classical and non-parametric ranking approaches.
Karadžić Banjac MŽ, Kovačević SZ, Jevrić LR, Podunavac-Kuzmanović SO, Mandić AI. Karadžić Banjac MŽ, et al. Among authors: podunavac kuzmanovic so. Comput Biol Chem. 2019 Jun;80:23-30. doi: 10.1016/j.compbiolchem.2019.03.001. Epub 2019 Mar 9. Comput Biol Chem. 2019. PMID: 30878814
Comprehensive QSRR modeling as a starting point in characterization and further development of anticancer drugs based on 17α-picolyl and 17(E)-picolinylidene androstane structures.
Kovačević SZ, Podunavac-Kuzmanović SO, Jevrić LR, Jovanov PT, Djurendić EA, Ajduković JJ. Kovačević SZ, et al. Among authors: podunavac kuzmanovic so. Eur J Pharm Sci. 2016 Oct 10;93:1-10. doi: 10.1016/j.ejps.2016.07.008. Epub 2016 Jul 11. Eur J Pharm Sci. 2016. PMID: 27418311
15 results